Tang Capital Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Buy |
4,889,200
+89,200
| +2% | +$321K | 0.89% | 36 |
|
|
2025
Q1 | $14.4M | Buy |
4,800,000
+11,088
| +0.2% | +$33.2K | 0.79% | 35 |
|
|
2024
Q4 | $16M | Buy |
4,788,912
+181,852
| +4% | +$609K | 1.06% | 25 |
|
|
2024
Q3 | $15.4M | Buy |
4,607,060
+130,319
| +3% | +$437K | 1.1% | 28 |
|
|
2024
Q2 | $14.8M | Buy |
4,476,741
+400,000
| +10% | +$1.32M | 1.51% | 22 |
|
|
2024
Q1 | $16.5M | Hold |
4,076,741
| – | – | 1.71% | 17 |
|
|
2023
Q4 | $12.4M | Buy |
4,076,741
+476,741
| +13% | +$1.45M | 1.15% | 24 |
|
|
2023
Q3 | $10.8M | Buy |
3,600,000
+573,545
| +19% | +$1.72M | 1.52% | 20 |
|
|
2023
Q2 | $11.3M | Buy |
3,026,455
+2,023,873
| +202% | +$7.57M | 1.67% | 20 |
|
|
2023
Q1 | $3.36M | Buy |
+1,002,582
| New | +$3.36M | 0.5% | 50 |
|